Epistaxis. A clinical study with special reference to fibrinolysis.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000740:Anemia / Q000150:complications; D001241:Aspirin / Q000009:adverse effects; D002648:Child; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004844:Epistaxis / Q000097:blood / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D005260:Female; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D006973:Hypertension / Q000150:complications; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa / Q000473:pathology; D012141:Respiratory Tract Infections / Q000150:complications
D003509:Cyclohexanecarboxylic Acids; D001241:Aspirin